Want to join the conversation?
$SPPI said it submitted an investigational new drug application to the US FDA and intends to initiate a Phase 2 breast cancer study in the US soon. The study is planned to be an open-label study enrolling approx. 70 patients with HER-2 positive metastatic breast cancer which will be treated with oral pan-HER inhibitor poziotinib.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.